Recent Finacing
Recent Raise
Scholar Rock develops biologic niche modulators that selectively inhibit supracellular activation of growth factors, including myostatin, to treat muscle disease, fibrosis, immuno-oncology, and autoimmune disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Scholar Rock.
